Team:SupBiotech-Paris/Bibliography

From 2009.igem.org

(Difference between revisions)
Line 26: Line 26:
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Current Therapies
|height=40px|Current Therapies
-
|[3]
+
|[1]
|Gouze JN and al.
|Gouze JN and al.
|A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer
|A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer
Line 33: Line 33:
|- style="background: #C0C0C0; text-align: center;"
|- style="background: #C0C0C0; text-align: center;"
|height=40px|Gene Therapies
|height=40px|Gene Therapies
-
|[1]
+
|[2]
|Kevin J. Scanlon and al.
|Kevin J. Scanlon and al.
|Cancer Gene Therapy: Challenges and Opportunities
|Cancer Gene Therapy: Challenges and Opportunities
Line 40: Line 40:
|- style="background: white; text-align: center;"
|- style="background: white; text-align: center;"
|height=40px|Gene Therapies
|height=40px|Gene Therapies
-
|[2]
+
|[3]
|Centre for Genetics Education
|Centre for Genetics Education
|http://www.genetics.com.au/index.asp
|http://www.genetics.com.au/index.asp

Revision as of 23:28, 19 October 2009

framless


Chapitre Ref. Auteurs Titre Lien
Current Therapies [1] Lechat P. Pharmacology 2006
Current Therapies [2] Bruguerolle B. Biological rhythms and medications: a source of variability often neglected in pharmacology 2008
Current Therapies [1] Gouze JN and al. A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer 2003
Gene Therapies [2] Kevin J. Scanlon and al. Cancer Gene Therapy: Challenges and Opportunities 2004
Gene Therapies [3] Centre for Genetics Education http://www.genetics.com.au/index.asp XXXX
Vectorization [1]
Vectorization [2]
Vectorization [3]
Vectorization [4]
Vectorization [5]
Vectorization [6]
Vectorization [7]
Vectorization [8]
Vectorization [9]
Vectorization [10]
Vectorization [11]
Vectorization [12]
Vectorization [13]
Vectorization [14]
Vectorization [15]
Tissue Vector [1] Ronald S. and al. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies 2009
Tissue Vector [2] Clark B. Inderlied and al. The Mycobacterium avium Complex 1993
Tissue Vector [3] Nisheeth Agarwal and al. Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase 2009
Tissue Vector [4] Hunter R.L. and al. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs 2007
Tissue Vector [5] Axelrod S and al. Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide 2008
Tissue Vector [6] Nicole N van der Wel and al. Subcellular localization of mycobacteria in tissues and detection of lipid antigens in organelles using cryo-techniques for light and electron microscopy 2005
Tissue Vector [7] Claudia Nobrega and al. The thymus as a target for mycobacterial infections 2007
Cell Vector [1] Harrison Echols and al. Genetic Map of Bacteriophage Lambda 1978
Cell Vector [2] Joseph Sambrook and al. Molecular Cloning: A Laboratory Manual (Third Edition) 2001
Cell Vector [3] Court DL and al. A New Look at Bacteriophage lambda Genetic Networks 2007
Cell Vector [4] Ortega ME and al. Bacteriophage Lambda gpNu1 and Escherichia coli IHF Proteins Cooperatively Bind and Bend Viral DNA: Implications for the Assembly of a Genome-Packaging Motor 2006
Cell Vector [5] Feiss M. and al. Bactériophage Lambda Terminase and the Mechanism of Viral DNA Packaging 2005
Cell Vector [6] Hang JQ and al. The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB 2001
Cell Vector [7] Becker A and al. Bacteriophage lambda DNA : The begginning of the End 1990
Cell Vector [8] Hochschild A and al. The bactériophage lambda cI protein finds an asymmetric solution 2009
Cell Vector [9] Phoebe L.Stewart1 and al. Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization 1997
Therapeutic Plasmide [1] Ortega ME et al. Bacteriophage lambda gpNu1 and Escherichia coli IHF proteins cooperatively bind and bend viral DNA: implications for the assembly of a genome-packaging motor 2006
Therapeutic Plasmide [2] Joseph Sambrook and al. Molecular Cloning: A Laboratory Manual (Third Edition) 2001
Therapeutic Plasmide [3] Court DL and al. A New Look at Bacteriophage lambda Genetic Networks 2007
Therapeutic Plasmide [4] Feiss M. and al. Viral Genome Packaging Machines: Genetics, Structure and Mechanism 2005
Therapeutic Plasmide [5] Hang JQ and al. The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB 2001
Therapeutic Plasmide [6] Becker A and al. Bacteriophage lambda DNA : The begginning of the End 1990
Therapeutic Plasmide [7] Young et al. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature 2003
[]


Back to top